Statistics for ADMA Biologics (id:6496 ADMA)

Valuation metrics

Market cap

4.50B

Enterprise value

4.53B

Trailing P/E (ttm)

70.52

Forward P/E

26.44

PEG ratio

26.44

Price/Sales (ttm)

11.76

Price/Book (mrq)

19.41

Enterprise Value/Revenue

11.82

Enterprise Value/EBITDA

35.95

Overview

Shares outstanding

236.39M

Float

232.10M

Shares short

15.20M

% Held by insiders

0.03%

% Held by institutions

0.91%

Average volume (10 days)

4.35M

Average volume (90 days)

Price summary

52-Week low

3.60

52-Week high

23.64

52-Week change

81.30%

Beta

0.64

50-Day moving average

18.54

200-Day moving average

11.86

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

17.80%

Operating margin

33.08%

Operational effectiveness

Return on assets

19.89%

Return on equity

35.55%

Income statement

Revenue (ttm)

1.66

Revenue per share (ttm)

1.66

Quarterly revenue growth (yoy)

13.00

Gross profit (ttm)

88.94M

EBITDA

125.01M

Net income to common (ttm)

68.13M

Diluted EPS (ttm)

0.27

Quarterly earnings growth (yoy)

1.30K%

Balance sheet

Total cash (mrq)

86.71M

Total cash per share (mrq)

0.37

Total debt (mrq)

111.38M

Total Debt/Equity (mrq)

48.03

Current ratio (mrq)

708.80%

Book value per share (mrq)

0.98

Cash flow

Cash flow statement

86.05M

Levered free cash flow (LFCF)

46.00M